Milestone Pharmaceuticals Inc

MIST NASDAQ Santé & Biotech Monde CA59935V1076
1.31 $
3.15 %

Milestone Pharmaceuticals se concentre sur le développement de thérapies cardiaques, notamment pour le traitement de la tachycardie ventriculaire paroxystique.

Performance & Momentum

6 Months 45.84 %
1 Year 23.03 %
3 Years 67.10 %
5 Years 79.01 %

Similar stocks to Milestone Pharmaceuticals Inc

Anantys Community

Be the first to share your analysis on Milestone Pharmaceuticals Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases